logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Akito Hata

roche holding japan
H指数:30
被引数:2,584

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biomarker analyses to predict benefit of immune checkpoint inhibitors for EGFR-mutated non-small cell lung cancer

EGFR突变非小细胞肺癌患者免疫检查点抑制剂疗效的预测生物标志物分析

Cancer Treatment and Research Communications
IF2.4
2026-02-010
OAAI
Azuma, Koichi; Osuga, Mitsuo; Itoh, Shoichi; Kawa, Yoshitaka; Kozuki, Toshiyuki; Toi, Yukihiro; Murotani, Kenta; Izumi, Motohiro; Murata, Daiki; Hata, Akito; Sugawara, Shunichi; Satouchi, Miyako; Yamamoto, Nobuyuki; Koh, Yasuhiro
Atezolizumab plus Chemotherapy for Advanced Non-Small Cell Lung Cancer in Japanese Clinical Practice (J-TAIL-2)

阿特珠单抗联合化疗治疗日本临床实践中晚期非小细胞肺癌（J-TAIL-2）

CANCER SCIENCE
IF4.3
2025-12-010
OAAI
Yoshioka, Hiroshige; Nishio, Makoto; Ohashi, Kadoaki; Osoegawa, Atsushi; Kikuchi, Eiki; Kimura, Hideharu; Goto, Yasushi; Shimizu, Junichi; Miyauchi, Eisaku; Yoshino, Ichiro; Misumi, Toshihiro; Watanabe, Yasutaka; Hata, Akito; Kisohara, Akira; Kuyama, Shoichi; Yamaguchi, Masafumi; Miwa, Asako; Iwasawa, Shunichiro; Tanaka, Misa; Gemma, Akihiko
Radiotherapy-free pembrolizumab combined with chemotherapy for locally advanced non-small-cell lung cancer with PD-L1 tumour proportion score of 50% or higher (Evolution trial): a multicentre, single-arm, phase 2 study

无放疗的帕博利珠单抗联合化疗治疗PD-L1肿瘤比例评分≥50%的局部晚期非小细胞肺癌（Evolution试验）：一项多中心、单臂、Ⅱ期研究

The Lancet Oncology
IF0
2025-10-110
PRE
Akito Hata; Taira Ninomaru; Hideaki Okada; Yoshihito Kogure; Masahide Oki; Nobuyuki Katakami; Takashi Kijima; Toshihide Yokoyama; Hirotaka Matsumoto; Yuki Sato; Terufumi Kato; Shunichi Sugawara; Takeshi Sawada; Kenichi Yoshimura; Takashi Seto; Kazuhiko Nakagawa; Isamu Okamoto; Nobuyuki Yamamoto
Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring EGFR Exon21 L858R mutation: a multicenter retrospective observational cohort study in Japan (REAL-SPEED)

Ramucirumab与erlotinib联合作为携带<i>EGFR</i>外显子21 L858R突变的晚期或复发非小细胞肺癌的一线治疗：一项在日本进行的多中心回顾性观察队列研究（REAL-SPEED）。

Therapeutic Advances in Medical Oncology
IF4.2
2025-06-160
OA
Masashi Ishihara; Takahisa Kawamura; Yukiko Namba; Yuki Takeyasu; Yukihiro Hasegawa; Yuki Sato; Yoshiki Negi; Tomohiro Oba; Toshiyuki Sumi; Hirokuni Hirata; Hidemitsu Funabashi; Yuko Oya; Hajime Kikuchi; Naoko Katsurada; Takeshi Nakatani; Keiko Tanimura; Taku Nakagawa; Naoya Takeda; Takahiro Asami; Osamu Honjo; Hiromi Nagashima; Takumi Yamaura; Norihiko Hata; Miyako Kitazono; Naoya Nishioka; Akihiro Tamiya; Yuichi Sakamori; Ryota Shigaki; Kyoichi Kaira; Ryoichi Honda; Takashi Matsui; Eriko Suzuki; Kentaro Ito; Kojiro Otsuka; Naoto Takase; Yusuke Murakami; Kazuhiko Matsuno; Sumito Inoue; Akira Kisohara; Sojiro Kusumoto; Hiroe Aoshima; Yumiko Kakizaki; Akihito Kubo; Akito Hata; Nobuhisa Ishikawa; Kosuke Hamai; Nobuhiro Kanaji; Toshihiro Misumi; Noriyuki Matsutani; Nobuhiko Seki
Intensity-Modulated Radiotherapy for Locally Advanced Lung Cancer in the Immunotherapy Era: A Prospective Study WJOG12019L

调强放射治疗在免疫治疗时代局部晚期肺癌中的应用：一项前瞻性研究 WJOG12019L

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2025-06-010
OAAI
Harada, Hideyuki; Hata, Akito; Konno, Masahiro; Mamesaya, Nobuaki; Nakamatsu, Kiyoshi; Haratani, Koji; Yamamoto, Takaya; Saito, Ryota; Mayahara, Hiroshi; Kokubo, Masaki; Sato, Yuki; Imano, Nobuki; Masuda, Takeshi; Fukuda, Haruyuki; Sado, Toshikatsu; Yoshimura, Kenichi; Nishimura, Yasumasa; Nakagawa, Kazuhiko; Okamoto, Isamu; Yamamoto, Nobuyuki
Neoadjuvant Concurrent Chemo–Immuno–Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L)

新辅助同步化免放疗法联合手术及辅助免疫疗法治疗可切除Ⅲ期N2非小细胞肺癌：SQUAT试验（WJOG 12119L）的初步结果

Journal of Thoracic Oncology
IF20.8
2025-04-090
PRE
Akira Hamada; Junichi Soh; Akito Hata; Kiyoshi Nakamatsu; Mototsugu Shimokawa; Yasushi Yatabe; Jun Suzuki; Masahiro Tsuboi; Hidehito Horinouchi; Yuichi Sakairi; Masayuki Tanahashi; Shinichi Toyooka; Morihito Okada; Natusmi Matsuura; Hisayuki Shigematsu; Yasumasa Nishimura; Nobuyuki Yamamoto; Kazuhiko Nakagawa; Tetsuya Mitsudomi
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA study

尼妥珠单抗联合顺铂和吉西他滨治疗在晚期肺鳞状细胞癌患者中诱导低镁血症的临床影响：NINJA研究的亚组分析

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2025-02-140
OA
Shigeru Tanzawa; Hiroshige Yoshioka; Toshihiro Misumi; Eisaku Miyauchi; Kiichiro Ninomiya; Yasunori Murata; Masafumi Takeshita; Fumihiko Kinoshita; Takatoshi Fujishita; Shunichi Sugawara; Yosuke Kawashima; Kazuki Hashimoto; Masahide Mori; Akihiko Miyanaga; Anna Hayashi; Hisashi Tanaka; Ryoichi Honda; Masafumi Nojiri; Yuki Sato; Akito Hata; Nobuhisa Ishikawa; Toshiyuki Kozuki; Takahisa Kawamura; Go Saito; Teppei Yamaguchi; Kazuhiro Asada; Satoshi Tetsumoto; Hiroshi Tanaka; Satoshi Watanabe; Yukihiro Umeda; Kakuhiro Yamaguchi; Kazuya Nishii; Kosuke Tsuruno; Yuki Misumi; Hiroshi Kuraishi; Ken Yoshihara; Akira Nakao; Akihito Kubo; Toshihiko Yokoyama; Kana Watanabe; Nobuhiko Seki
Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study

广泛期小细胞肺癌根据关键临床试验入组标准进行的化疗免疫疗法长期预后：一项前瞻性队列研究的3年结果

LUNG CANCER
IF4.4
2025-01-010
PRE
Sugisaka, Jun; Fujimoto, Daichi; Tamiya, Motohiro; Hata, Akito; Matsumoto, Hirotaka; Yokoyama, Toshihide; Taniguchi, Yoshihiko; Uchida, Junji; Sato, Yuki; Kijima, Takashi; Tanaka, Hisashi; Furuya, Naoki; Masuda, Takeshi; Sakata, Yoshihiko; Miyauchi, Eisaku; Saito, Go; Miura, Satoru; Yamaguchi, Teppei; Daga, Haruko; Sakata, Shinya; Yamamoto, Nobuyuki; Akamatsu, Hiroaki
Sequential afatinib (AFA) to osimertinib (OSI) in EGFR-mutant NSCLC: An exploratory analysis of initial AFA dosage in Gio-Tag Japan, a multicenter prospective observational study

EGFR突变非小细胞肺癌中阿法替尼（AFA）序贯奥希替尼（OSI）治疗：基于Gio-Tag Japan多中心前瞻性观察研究的初始阿法替尼剂量探索性分析

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Hata, A.; Takase, N.; Sumi, T.; Yoshioka, H.; Fujisaka, Y.; Ota, T.; Osugi, J.; Mitsui, M.; Morita, R.; Morita, S.; Sakai, K.; Nishio, K.; Katakami, N.
The potential of VEGF-A in the peripheral blood serum as a biomarker of response in the addition of bevacizumab with chemotherapy-combined immunotherapy for metastatic nonsquamous non-small cell lung cancer

外周血血清中VEGF-A作为生物标志物的潜力，用于评估贝伐珠单抗联合化疗与免疫疗法相结合对转移性非鳞非小细胞肺癌的治疗反应。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Sugisaka, J.; Tanaka, K.; Shiraishi, Y.; Watanabe, Y.; Daga, H.; Azuma, K.; Nishino, K.; Mori, M.; Terashima, M.; Saito, H.; Hata, A.; Sakaguchi, T.; Kozuki, T.; Yamamoto, N.; Nakagawa, K.; Okamoto, I.
Real-World Pharmacokinetics, Effectiveness, and Safety of Atezolizumab in Patients With Unresectable Advanced or Recurrent NSCLC: An Exploratory Study of J-TAIL
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2024-07-011
OA
Yagishita, Shigehiro; Goto, Yasushi; Nishio, Makoto; Akamatsu, Hiroaki; Hayashi, Hidetoshi; Miura, Satoru; Tamada, Koji; Kagamu, Hiroshi; Hamada, Akinobu; Ohuchi, Mayu; Gemma, Akihiko; Yoshino, Ichiro; Misumi, Toshihiro; Hata, Akito; Hara, Satoshi; Kijima, Takashi; Masaki, Fujita; Iwasawa, Shunichiro; Nakagawa, Shintaro; Tatsuno, Masahiro; Mitsudomi, Tetsuya
Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis

疑似脑膜癌病的肺癌患者脑脊液肿瘤DNA的定量分析

NPJ PRECISION ONCOLOGY
IF8
2024-05-284
OAAI
Azad, Tej D.; Nanjo, Shigeki; Jin, Michael C.; Chabon, Jacob J.; Kurtz, David M.; Chaudhuri, Aadel A.; Connolly, Ian D.; Hui, Angela Bik-Yu; Liu, Chih Long; Merriott, David; Ko, Ryan; Yoo, Christopher; Carter, Justin; Chen, Emily; Bonilla, Rene; Hata, Akito; Katakami, Nobuyuki; Irie, Kei; Yano, Seiji; Okimoto, Ross; Bivona, Trever G.; Newman, Aaron M.; Iv, Michael; Nagpal, Seema; Gephart, Melanie Hayden; Alizadeh, Ash A.; Diehn, Maximilian
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer
BRITISH JOURNAL OF CANCER
IF6.8
2024-03-220
PRE
Haratani, Koji; Nakamura, Atsushi; Mamesaya, Nobuaki; Sawa, Kenji; Shiraishi, Yoshimasa; Saito, Ryota; Tanizaki, Junko; Tamura, Yosuke; Hata, Akito; Tsuruno, Kosuke; Sakamoto, Tomohiro; Teraoka, Shunsuke; Oki, Masahide; Watanabe, Hiroshi; Tokito, Takaaki; Nagata, Kenji; Masuda, Takeshi; Nakamura, Yasushi; Sakai, Kazuko; Chiba, Yasutaka; Ito, Akihiko; Nishio, Kazuto; Yamamoto, Nobuyuki; Nakagawa, Kazuhiko; Hayashi, Hidetoshi
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2023-12-014
OA
Murata, Yasunori; Tanzawa, Shigeru; Misumi, Toshihiro; Yoshioka, Hiroshige; Miyauchi, Eisaku; Ninomiya, Kiichiro; Takeshita, Masafumi; Ito, Kensaku; Okamoto, Tatsuro; Sugawara, Shunichi; Kawashima, Yosuke; Hashimoto, Kazuki; Mori, Masahide; Miyanaga, Akihiko; Hayashi, Anna; Tanaka, Hisashi; Honda, Ryoichi; Nojiri, Masafumi; Sato, Yuki; Hata, Akito; Masuda, Ken; Kozuki, Toshiyuki; Kawamura, Takahisa; Suzuki, Takuji; Yamaguchi, Teppei; Asada, Kazuhiro; Tetsumoto, Satoshi; Tanaka, Hiroshi; Watanabe, Satoshi; Umeda, Yukihiro; Yamaguchi, Kakuhiro; Kuyama, Shoichi; Tsuruno, Kosuke; Misumi, Yuki; Kuraishi, Hiroshi; Yoshihara, Ken; Nakao, Akira; Kubo, Akihito; Yokoyama, Toshihiko; Watanabe, Kana; Seki, Nobuhiko

研究方向

暂未获取到该数据
N
Nobuyuki Yamamoto
H 指数:73论文数:1,055被引数:2.9万
N
Nobuyuki Katakami
H 指数:54论文数:363被引数:1.6万
K
Kazuhiko Nakagawa
H 指数:103论文数:1,451被引数:6.1万
M
Motohiro Tamiya
H 指数:32论文数:372被引数:3,561
H
Hiroshige Yoshioka
H 指数:49论文数:356被引数:1.6万
S
Satoru Miura
H 指数:29论文数:289被引数:3,414
Y
Yuki Sato
H 指数:27论文数:225被引数:2,714
K
Keisuke Tomii
H 指数:50论文数:433被引数:9,149
S
Satoshi Hara
H 指数:30论文数:393被引数:3,512
D
Daichi Fujimoto
H 指数:35论文数:243被引数:3,954